Molecular biology of Hodgkin's disease

Cancer Surveys

Volumn 30, Issue , 1997, Pages 107-123

  Stein, Harald ^a   Hummel, Michael ^a   Marafioti, Theresa ^a   Anagnostopoulos, Ioannis ^a   Foss, Hans Dieter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN SPECIFICITY; CANCER CLASSIFICATION; CHROMOSOME ABERRATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; REED STERNBERG CELL; REVIEW; TUMOR SUPPRESSOR GENE; VIRUS INFECTION;

CHROMOSOME ABERRATIONS; GENES, TUMOR SUPPRESSOR; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; ONCOGENES; RECEPTORS, ANTIGEN, T-CELL; REED-STERNBERG CELLS;

EID: 0030880866     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Amakawa R, Hakem A, Kundig TM et al. (1996) Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84 551-561
2. Anagnostopoulos I, Herbst H, Niedobitek G and Stein H (1989) Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern and in situ hybridization. Blood 74 810-816
3. Anderson P, Nagler-Anderson C, O'Brien C et al. (1990) A monoclonal antibody reactive with a 15-kDa cytoplasmic granule associated protein defines a subpopulation of CD8+ T lymphoctes. Journal of Immunology 144 574-582
4. Andreesen R, Osterholz J, Lohr GW and Dross KJ (1984) A Hodgkin's cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. Blood 63 1299-1302
5. Andreesen R, Brugger W, Lohr GW and Bross KJ (1989) Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30). American Journal of Pathology 134 187192
6. Chan WC and Delabie J (1996) Single cell analysis of H/RS cells. Annals of Oncology 7 (Supplement 4) 41-44
7. Chilosi M, Doglioni C, Menestrina F et al. (1994) Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease. Blood 84 4295-4300
8. Daus H, Trümper L, Roth J et al. (1995) Hodgkin and Reed-Sternberg cells do not carry T-cell receptor γ gene rearrangements: evidence from single-cell polymerase chain reaction examination. Blood 85 1590-1595
9. Deerberg-Wittram J, Weber-Matthiesen K and Schlegelberger B (1996) Cytogenetics and molecular cytogenetics in Hodgkin's disease. Annals of Oncology 7 (Supplement 4) 49
10. Delabie J, Tierens A, Wu G, Weisenburger DD and Chan WC (1994) Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using single cell assay. Blood 84 3291-3298
11. Delsol G, Brousset P, Chittal S and Rigal-Huguet F (1992) Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamIII-W probes in Hodgkin's disease. American Journal of Pathology 140 247-253
12. Doglioni C, Pelosio P, Mombello A, Scarpa A and Chilosi M (1991) Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas. Hematological Pathology 5 67-73
13. Döhner H, Bloomfield CD, Frizzera G and Arthur DC (1989) Recurring chromosome abnormalities in Hodgkin's disease. Blood 74 82a
14. Doussis IA, Pezzella F, Lane DP, Gatter KC and Mason DY (1993) An immunocytochemical study of p53 and bcl-2 protein expression on Hodgkin's disease. American Journal of Clinical Pathology 99 663-667
15. Fonatsch C, Diehl V, Schaadt M, Burrichter H and Kirchner HH (1986) Cytogenetic investigations in Hodgkin's disease. I, Involvement of specific chromosomes in marker formation. Cancer Genetics and Cytogenetics 20 39-52
16. Foss HD, Anagnostopoulos I, Araujo I et al. (1996) Anaplastic large cell lymphoma of T-cell and null-cell phenotype express cytotoxic molecules. Blood 88 4005-4011
17. Gruss HJ, Davis T, Anderson D et al. (1993) CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73 1349-1360
18. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA and Goodwin RG (1994) Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83 2045-2056
19. Gulley ML, Eagan OA, Quintanilla-Martinez L et al. (1994) Epstein-Barr virus is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood 83 1595-1602
20. Gupta RK, Whelan JS, Lister TA, Young BD and Bodmer JG (1992) Direct sequence analysis of the t(14;18) chromosomal translocation in Hodgkin's disease. Blood 79 2084-2088
21. Gupta RK, Patel K, Bodmer WF and Bodmer JG (1993) Mutation of p53 in primary biopsy material and cell lines from Hodgkin's disease. Proceedings of the National Academy of Sciences of the USA 90 2817-21
22. Haines DS, Landers JE, Engle LJ and George DL (1994) Physical and functional interaction between wild-type p53 and mdm2 proteins. Molecular and Cellular Biology 14 1171-1178
23. Harris NL, Jaffe E, Stein H et al. (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 1361-1392
24. Henderson S, Rowe M, Croom-Carter D et al. (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65 1107-1115
25. Herbst H, Tippelmann G, Anagnostopoulos I et al. (1989) Immunoglobulin and T cell receptor gene rearrangements in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma: dissociation between phenotype and genotype. Leukemia Research 13 103-116
26. Herbst H, Dallenbach F, Hummel M et al. (1991) Epstein-Barr virus latent membrane protein expression in Hodgkin- and Reed-Sternberg cells. Proceedings of the National Academy of Sciences of the USA 88 4766-4770
27. Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C and Stein H (1992) EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. British Journal of Haematology 82 689-694
28. Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E and Stein H (1995) Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. New England Journal of Medicine 333 901-906
29. Hummel M, Marafioti T and Stein H (1996a) Response to the letter to the editor. New England Journal of Medicine 334 405
30. Hummel M, Marafioti T, Ziemann K and Stein H (1996b) Ig rearrangements in isolated Reed-Sternberg cells: conclusions from four different studies. Annals of Oncology 7 (Supplement 4) 31-33
31. Jackson H and Parker F (1944) Hodgkin's disease. II, Pathology. New England Journal of Medicine 231 35-44
32. Jenne DE and Tschopp J (1988) Granzymes: a family of serine proteases released from granules of cytotoxic T lymphocytes upon T cell receptor stimulation. Immunology Review 103 5371
33. Jucker M, Schaadt M, Diehl V, Poppema S, Jones D and Tesch H (1990) Heterogeneous expression of proto-oncogenes in Hodgkin's disease derived cell lines. Hematological Oncology 8 191-204
34. Kanzler H, Küppers R, Hansmann M-L et al. (1996) Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. Joumal of Experimental Medicine 184 1-11
35. Knecht H, Odematt BF, Bachmann E et al. (1991) Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- or T-cell clonaliry. Blood 78 760-767
36. Knowles DM, Neri A, Pelicci PG et al. (1986) Immunoglobulin and T cell receptor beta-chain gene rearrangement analysis of Hodgkin's disease: implications for lineage determination and differential diagnosis. Proceedings of the National Academy of Sciences of the USA 83 7942-7946
37. Küppers R, Zhao M, Hansmann ML and Rajewski K (1993) Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO Journal 12 4955-4967
38. Küppers R, Rajewsky K, Zhao M et al. (1994) Hodgkin's disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proceedings of the National Academy of Sciences of the USA 91 10962-10966
39. Küppers R, Hansmann M-L, Diehl V and Rajewsky K (1995) Molecular single cell analysis of Hodgkin and Reed-Sternberg cells. Molecular Medicine Today 1 26-30
40. Küppers R, Kanzler H, Hansmann M-L and Rajewsky K (1996a) Letter to the editor. New England journal of Medicine 334 404
41. Küppers R, Kranzler H, Hansmann M-L and Rajewsky K (1996b) Single cell analysis of Hodgkin/Reed-Sternberg cells. Annals of Oncology 7 (Supplement 4) 27-30
42. Lauritzen AP, Pluzek KJ, Kristensen IE and Nielsen HW (1992) Detection of immunoglobulin light-chain mRNA in nodular sclerosing Hodgkin's disease by in situ hybridization with biotinylated oligonucleotide probes compared with immunohistochemical staining with poly- and monoclonal antibodies. Histopathology 21 353-358
43. Lichtenberg MG and Podack ER (1989) Structure of the human perform gene. A simple gene organization with interesting potential regulatory sequences. Journal of Immunology 143 4267
44. Lukes RJ and Butler JJ (1966) The pathology and nomenclature of Hodgkin's disease. Cancer Research 26 1063-1081
45. Lukes RJ, Craver LF, Hall TC, Rappaport H and Ruben P (1966) Report of the nomenclature committee. Cancer Research 26 1311
46. Mason DY, Banks PM, Chan J et al. (1994) Nodular lymphocyte predominance Hodgkin's disease: a distinct clinico-pathological entity. American Journal of Surgical Pathology 18 52630
47. Mechtesheimer G and Möller P (1990) Expression of Ki-1 antigen (CD30) in mesenchymal tumors. Cancer 66 1732-1737
48. Mitani S, Sugawara I, Shiku H and Mori S (1988) Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques. Cancer 62 2085-2093
49. Nicholas DS, Harris S and Wright DH (1990) Lymphocyte predominance Hodgkin's disease - an immunohistochemical study. Histopathology 16 157-165
50. O'Conner N, Crick JA, Gatter KC, Mason DY, Falini B and Stein H (1987) Cell lineage in Hodgkin's disease. Lancet i 158
51. Oliner JD (1993) Discerning the function of p53 by examining its molecular interactions. BioEssays 15 703-707
52. Oudejans JJ, Kummer JA, Jiwa M et al. (1996) Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease. American Journal of Pathology 148 233-240
53. Pallesen G, Hamilton-Dutoit SJ, Rowe M and Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 337 320-322
54. Pinkus GS and Said JW (1988) Hodgkin's disease, lymphocyte predominance type, nodular: further evidence for a B cell derivation. American Journal of Pathology 133 211-217
55. Rajewsky K (1996) Clonal selection and learning in the antibody system. Nature 381 751-758
56. Roth J, Daus H, Trümper L et al. (1994) Detection of immunoglobulin heavy-chain gene rearrangement at the single-cell level in malignant lymphomas: no rearrangement is found in Hodgkin and Reed-Sternberg cells. International Journal of Cancer 57 1-6
57. Ruprai AK, Pringle JH, Angel CA, Kind CN and Lauder I (1991) Localization of immunoglobulin light-chain mRNA expression in Hodgkin's disease by in situ bybridization. Journal of Pathology 164 37-40
58. Schlegelberger B, Weber-Matthiesen K et al. (1994) Cytogenetic findings and results of combined immunophenotyping and karyotyping in Hodgkin's disease. Leukemia 8 72-80
59. Schwab U, Stein H, Gerdes J et al. (1982) Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's lymphoma and a subset of normal lymphoid cells. Nature 299 65-67
60. Sklar M and Kitchingham G (1985) Isolation of activated ras transforming genes from two patients with Hodgkin's disease. International Journal of Radiation, Oncology, Biology and Physics 11 49-55
61. Sohail D and Simpson RH (1990) Ber-H2 staining of lipoblasts. Histopathology 18 409-413
62. Steenvoorden AC, Janssen JW, Drexler HD et al. (1988) Ras mutations in Hodgkin's disease. Leukemia 2 325-326
63. Stein H, Gerdes J, Schwab U et al. (1982) Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly detected small cell population. International Journal of Cancer 30 445-459
64. Stein H, Gerdes J, Lemke H, Gatter KC and Mason DY (1984) Immunohistological classification of Hodgkin's disease and malignant histiocytosis, In: Ford RJ, Fuller LM, Hagermeister FB and Ut MD (eds). New Perspectives in Human Leukaemia: Anderson Clinical Conference on Cancer, vol 27, pp 35-47, Raven Press, New York
65. Stein H, Mason DY, Gerdes J et al. (1985) The expression of the Hodgkin's disease-associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66 848-858
66. Stein H, Hansmann MI, Lennert K, Brandtzaeg P, Gatter KC and Mason DY (1986) Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. American Journal of Clinical Pathology 86 292-297
67. Stein H, Schwarting R, Dallenbach D and Dienemann D (1989) Immunology of Hodgkin and Reed-Sternberg Cells. Recent Results in Cancer Research 117 14-26
68. Stein H, Herbst H, Anagnostopoulos I, Niedobitek G, Dallenbach F and Kratzsch H-C (1991) The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Annals of Oncology 2 (Supplement 2) 33-38
69. Sundeen J, Lipford E, Uppenkamp M et al. (1987) Rearranged antigen receptor genes in Hodgkin's disease. Blood 70 96-103
70. H genes. Blood 84 708-715
71. Teerenhovi L, Lindholm C, Pakkala A, Franssila K, Stein H and Knuutila S (1988) Unique display of a pathologic karyotype in Hodgkin's disease by Reed-Sternberg cells. Cancer Genetics and Cytogenetics 34 305-311
72. Tian Q, Streuli M, Saito H, Schlossman SF and Anderson P (1991) A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67 629-639
73. Tilly H, Bastard C, Delastre T et al. (1991) Cytogenetic studies in untreated Hodgkin's disease. Blood 77 1298-1304
74. Trümper LH, Brady G, Bagg A et al. (1993) Single-cell analysis of Hodgkin and Reed-Sternberg cells: molecular heterogeneity of gene expression and p53 mutation. Blood 81 3097-3115
75. Weber-Matthiesen K, Winkemann M, Muller-Hermelink A, Schlegelberger B and Grote W (1992) Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. Journal of Histochemisty Cytochemistry 40 171-175
76. Weber-Matthiesen K, Deerberg J, Poetsch M, Grote W and Schlegelberger B (1995) Numerical chromosome aberrations are present within the CD30-positive Hodgkin and ReedSternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood 86 1464-1464
77. Weiss LM, Strickler JG, Hu E, Warnke RA and Sklar J (1986) Immunoglobulin gene rearrangements in Hodgkin's disease. Human Pathology 17 1009-1014
78. Weiss LM, Strickler JG, Warnke RA, Purtilo DT and Sklar J (1987) Epstein-Barr viral DNA in tissues of Hodgkin's disease. American Journal of Pathology 129 86-91
79. Weiss LM, Movahed AM, Warnke RA and Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. New England Journal of Medicine 320 502-506
80. Weiss LM, Chen YY, Lui XF and Shibata D (1991) Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. American Journal of Pathology 139 1259-1265
81. Zauberman A, Barak Y, Ragimov N, Levy N and Oren M (1993) Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53-MDM2 complexes. EMBO Journal 12 2799-2808